Combining MYC, BCL-2 and TP53 gene and protein expression alterations improves risk stratification in diffuse large B-cell lymphoma.

Added 2546 days ago (08.10.2014)
Authors: Fiskvik I, Beiske K, Delabie J, Yri O, Spetalen S, Karjalainen-Lindsberg ML, Leppä S, Liestøl K, Smeland EB, Holte H
PubMed id: 25284491
Read article